1Jiang HC, Gao Y, Dai W J, et al. Ten-year experience with living related donated splenic transplantation for the treatment of hemophilia A[ J ]. Transplant Proc ,2006,38 (5) : 1483-1490.
2John PG, John F, John NL, et al. Wintrobe' s Clinical Hematology [ M ]. 11th ed. Philadelphia: Lippincott Williams & Wilkins ,2004 : 1620-1658.
3Murugan S J, Viswanathan S, Thomson J, et al. Heart surgery in infants with hemophilia [J]. Ann Thorac Surg, 2006, 81 ( 1 ) : 336-339.
4Sadat U, Naik J, Hayes PD. Surgical complications in a hemophilia patient with factor VIII inhibitor and their endovascular management [ J ]. Vasc Endovascular Surg,2008,42 (2) : 168-172.
5Pruthi RK, Mathew P, Valentino LA, et al. Haemostatic efficacy and safety of bolus and continuous infusion of recombinant factor VIIa are comparable in haemophilia patients with inhibitors undergoing major surgery. Results from an open-label, randomized, multicenter trial[J]. Thromb Haemost,2007,98(4) :726-732.
6Morfini M, Haya S, Tagariello G, et al. European study on orthopaedic status of haemophilia patients with inhibitors [ J ]. Haemophilia, 2007,13 (5) :606-612.
7Rodriguez-Merchan EC, Quintana M, Jimenez-Yuste V, et al. Orthopaedic surgery for inhibitor patients : a series of 27 procedures (25 patients) [ J ]. Haemophilia ,2007,13 (5) :613-619.
8Thankachen R, George B, Shukla V, et al. Aortic and mitral valve replacement in a patient with hemophilia B [ J ]. Asian Cardiovasc Thorac Ann ,2007,15 (6) :526-527.
9Smith MP, Ludlam CA, Collins PW, et al. Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VIII:plasma factor VIII activity of lOIU/ml is associated with an increased incidence of bleeding [ J ]. Thromb Haemost,2001,86(4) :949-953.
10Gouw SC,van den Berg HM, le Cessie S, et al. Treatment characteristics and the risk of inhibitor development:a multicenter cohort study among previously untreated patients with severe hemophilia A [J]. Thromb Haemost,2007,5 (7) : 1383-1390.
